Phytotecnia is offering 25% of its shares to people that believe in the potential of medicinal cannabis and would like to become part-owners of a company with very high ethical standards that govern the way we do things.
We want to become a reference because of the way we do things more than because of what we do
Medicinal cannabis came to us naturally three years ago looking for our expertise. Initially sceptical about the potential of cannabis as a medicine, we soon became completely convinced about its possibilities. At the same time we realised the enormous challenges that a business in this industry would face: lack of scientific knowledge in basic areas of cultivation and manufacturing; emerging markets with evolving demands; and fast developing and diverse regulatory frameworks. In this context, we believe that the only possible approach to succeed in the industry is a learner’s approach: understand and acknowledge the complexity of the medicinal cannabis industry and develop a business model based on expertise, intelligence, patience and hard work.
Our approach avoids speculation and misleading information, and acknowledges the legacy of those that have been working with cannabis, frequently underground, for many years.